Skip to main content

Table 1 Clinical characteristics.

From: Changes in spatiotemporal gait variables over time during a test of functional capacity after stroke

 

Entire cohort (n = 24)

Rest group (n = 7)

No Rest Group (n = 17)

Between-group p value

Age (years)

63 ± 13 (38 – 86)

68 ± 15 (38 – 86)

61 ± 12 (41 – 83)

0.26

Gender (M/F)

17/7

14/3

4/3

0.4

Time post stroke (months)

38 ± 26 (12 – 121)

43 ± 38 (12 – 121)

37 ± 21 (16 – 92)

0.6

Stroke type (infarct/hemorrhage/unknown)

14/8/2

5/2/0

9/6/2

0.6

Body side affected (left/right/bilateral)

11/12/1

4/3/0

7/9/1

0.7

CMSA leg

5 ± 1 (2 – 7)

5 ± 1 (2 – 6)

5 ± 1 (3 – 7)

0.8

NIH

4 ± 2 (0 – 9)

4 ± 1 (3 – 7)

/4 ± 2 (0 – 9)

0.6

Gait aid (aid/no aid)

13/11

5/2

8/9

0.3

VO2peak (ml/kg-min)

14.9 ± 4.6 (8.0 – 24.5)

12.5 ± 5.3 (8 – 22.5)

16.1 ± 4.0 (27.8 – 129.7)

0.1

HRpeak (beats/min)

113.3 ± 4.5 (80.0 – 148.0)

115.9 ± 5.8 (80.0 – 148.0)

108.0 ± 7.1 (90.0 – 142.0)

0.4

Preferred gait speed (cm/s)

76.2 ± 29.2 (27.8 – 129.7)

77.5 ± 25.0 (29.2 – 96.6)

75.7 ± 31.6 (0.85 – 2.46)

0.9

Preferred gait symmetry ratio

1.44 ± 0.58 (0.85 – 2.9)

1.58 ± 0.76 (14 – 52)

1.38 ± 0.5 (39–56)

0.5

Berg Balance Scale

46.7 ± 11.5 (14 – 56)

37.6 ± 15.7 (14 – 52)

51.3 ± 4.6 (39 – 56)

0.006

Total 6MWT distance (m)

283.3 ± 136.8 (55 – 552)

205.7 ± 111.3 (55 – 327)

315.2 ± 136.1 (108 – 552)

0.07

HR at end of 6MWT (beats/min)

96.3 ± 20.3 (70 – 151)

98 ± 20 (80 – 134)

95.5 ± 21.2 (70 – 151)

0.8

HR at end of 6MWT (% of HRpeak)

86.8 ± 3.9 (42 – 115)

84.1 ± 4.7 (49 – 114)

92.1 ± 7.2 (67 – 115)

0.3

RPE at end of 6MWT

4 ± 2 (1 – 10)

5 ± 1 (3 – 10)

3 ± 1 (1 – 5)

0.04